Narrative review highlights chemopreventive agents' role in managing oral disorders and cancer, suggesting improved outcomes.
Chemopreventive medicines, especially when utilised in combination and through sophisticated delivery systems, signify a prospective adjunct or alternative approach in the care of OPMDs and OSCC, with the capacity to diminish disease burden and enhance patient outcomes.
No takes yet. Share an insight, caveat, or question.
Sayal et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: